[1] 贾晓旭,田利霞. 鄂尔多斯市居民中药用药安全行为风险KAP调查研究[J]. 光明中医,2023,38(3):568-572. [2] 张可人,杨宁菊. 贵阳市居民安全用药现状调查分析[J]. 中国医药导刊,2022,24(4):423-426. [3] Antoon JW, Feinstein JA, Goldman JL, et al.Advancing pediatric medication safety using real-world data: Current problems and potential solutions[J]. J Hosp Med, 2023, 18(9): 865-869. [4] Kim S, Kang T, Chung TK, et al.Automatic extraction of comprehensive drug safety information from adverse drug event narratives in the Korea Adverse Event Reporting System using natural language processing techniques[J]. Drug Saf, 2023, 46(8): 781-795. [5] Bell T, Sprajcer M, Flenady T, et al.Fatigue in nurses and medication administration errors: A scoping review[J]. J Clin Nurs, 2023, 32(17-18): 5445-5460. [6] Fusaroli M, Salvo F, Bégaud B, et al.The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): Development and statement[J]. Drug Saf, 2024, 47(6): 575-584. [7] 吴文宇,范玉婷,甘雨君,等. 深圳市居民安全用药行为及影响因素研究[J]. 华南预防医学,2023,49(12):1521-1525. [8] Viechtbauer W, Smits L, Kotz D, et al.A simple formula for the calculation of sample size in pilot studies[J]. J Clin Epidemiol, 2015, 68(11): 1375-1379. [9] 国家卫生健康委办公厅. 关于印发医疗机构药学门诊服务规范等5项规范的通知:国卫办医函[2021]520号[EB/OL]. (2021-10-09)[2024-11-06]. http://www.nhc.gov.cn/yzygj/s7659/202110/7cf93bfa4c814c1fa1c8e0b2e3d5e4f5.shtml. [10] 侯文婧,沈素,温爱萍,等. 《用药安全文化建设标准》制订与解析[J]. 医药导报,2024,43(7):1079-1083. [11] 国家卫生健康委员会. 《关于印发加强医疗机构药事管理促进合理用药的意见的通知》政策解读[J]. 中国实用乡村医生杂志,2020,27(4):1-2. [12] 张青霞,李思妍,白向荣,等. 全国临床安全用药监测网年度报告(2023年)[J]. 药物不良反应杂志,2024,26(7):390-398. [13] Vamos CA, Thompson EL, Griner SB, et al.Applying organizational health literacy to maternal and child health[J]. Matern Child Health J, 2019, 23(5): 597-602. [14] 修帆,袁平,罗丽,等. 2022年居民用药安全行为风险KAP调查研究[J]. 临床合理用药,2024,17(17):6-9,13. [15] Davis SE, Zabotka L, Desai RJ, et al.Use of electronic health record data for drug safety signal identification: A scoping review[J]. Drug Saf, 2023, 46(8): 725-742. [16] Aschenbrenner DS.Safe practices for medication administration via enteral tubes[J]. Am J Nurs, 2023, 123(5): 22-23. [17] De Vries E, Bakker E, Monster TBM, et al.Factors influencing preferences and responses towards drug safety communications: A conjoint experiment among hospital-based healthcare professionals in the Netherlands[J]. Drug Saf, 2022, 45(11): 1369-1380. [18] Saleem F, Malik MI.Safety management and safety performance nexus: Role of safety consciousness, safety climate, and responsible leadership[J]. Int J Environ Res Public Health, 2022, 19(20): 13686. [19] Winterfeld U.Bridging the evidence gap: Sotrovimab use in pregnancy and the need for comprehensive drug safety data[J]. Drug Saf, 2024, 47(9): 841-842. [20] 高永平,张玲玲,王小红,等. 某三甲医院心血管内科住院的老年患者参与口服用药安全行为的现状及相关影响因素[J]. 中国老年学杂志,2022,42(10):2513-2518. [21] 薄纯光,魏新宇,赵金奎,等. 农村地区用药现状分析及其对药学职业教育的启示[J]. 临床医药文献电子杂志,2022,9(29):114-116. [22] 刘国珍,薛承斌,丁玉峰,等. 湖北某高校社区居民安全用药现状调查以及用药风险因素分析[J]. 中国医院药学杂志,2021,41(17):1795-1800. [23] 迟晨汝,周志庆,刘欢,等. 老年慢性病住院患者安全用药行为现状及影响因素分析[J]. 长治医学院学报,2022,36(6):414-417,422. [24] 杨鹏路,杨彬,凌燕,等. 健康管理视角下多重慢病患者用药安全与药物管理策略[J]. 中华健康管理学杂志,2024,18(8):631-635. |